by Commetric | Jun 10, 2023
The 2023 ASCO Annual Meeting presented a multitude of clinical research data on cancer care practices, with a major focus on advancements in breast cancer treatment. Our media analysis found that Novartis’ Kisqali was widely praised for its promise of boosting...
by Commetric | Sep 26, 2022
This year’s European Society for Medical Oncology (ESMO) Congress was closely followed by specialised pharma outlets and managed to generate interest in daily media as well. Our media analysis found that a new study linking pollution...
by Commetric | Aug 5, 2022
A new UCL study made headlines for “debunking” the serotonin imbalance theory of depression and caused a Twitter storm. Our media analysis found that the reaction from many researchers suggested that the serotonin imbalance theory has not been treated seriously...
by Commetric | Jul 27, 2022
The European Hematology Association’s (EHA) 2022 Hybrid Congress was covered widely by specialised pharma media outlets like Hematology Advisor, Fierce Biotech and Medscape, as well as some business publications like Reuters and Seeking Alpha. To see what stood out...
by Commetric | Jul 22, 2022
The European Hematology Association’s 2022 Congress saw many pharma companies present their latest work in blood cancer research. Our analysis found that lymphoma became the focus of the media debate around EHA 2022, while companies that reported M&A deals...